These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30791232)

  • 81. PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer.
    Yin XK; Wang YL; Wang F; Feng WX; Bai SM; Zhao WW; Feng LL; Wei MB; Qin CL; Wang F; Chen ZL; Yi HJ; Huang Y; Xie PY; Kim T; Wang YN; Hou JW; Li CW; Liu Q; Fan XJ; Hung MC; Wan XB
    Oncogene; 2021 Feb; 40(7):1375-1389. PubMed ID: 33420374
    [TBL] [Abstract][Full Text] [Related]  

  • 82. MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.
    Shen H; Xing C; Cui K; Li Y; Zhang J; Du R; Zhang X; Li Y
    Cell Death Differ; 2017 Jul; 24(7):1253-1262. PubMed ID: 28475173
    [TBL] [Abstract][Full Text] [Related]  

  • 83. RNF141 interacts with KRAS to promote colorectal cancer progression.
    Zhang J; Jiang X; Yin J; Dou S; Xie X; Liu T; Wang Y; Wang S; Zhou X; Zhang D; Jiang H
    Oncogene; 2021 Sep; 40(39):5829-5842. PubMed ID: 34345014
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Aberrant methylation of miR-124 upregulates DNMT3B in colorectal cancer to accelerate invasion and migration.
    Shahmohamadnejad S; Nouri Ghonbalani Z; Tahbazlahafi B; Panahi G; Meshkani R; Emami Razavi A; Shokri Afra H; Khalili E
    Arch Physiol Biochem; 2022 Dec; 128(6):1503-1509. PubMed ID: 32552060
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells.
    Satow R; Hirano T; Batori R; Nakamura T; Murayama Y; Fukami K
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13505-10. PubMed ID: 25197077
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Aberrant methylation in neurofunctional gene serves as a hallmark of tumorigenesis and progression in colorectal cancer.
    Li X; Cai D; Huang Y; Xie Y; Shen D; Yuan Z; Liu X; Huang M; Luo Y; Yu H; Wang X
    BMC Cancer; 2023 Apr; 23(1):315. PubMed ID: 37020199
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
    Fessler E; Jansen M; De Sousa E Melo F; Zhao L; Prasetyanti PR; Rodermond H; Kandimalla R; Linnekamp JF; Franitza M; van Hooff SR; de Jong JH; Oppeneer SC; van Noesel CJ; Dekker E; Stassi G; Wang X; Medema JP; Vermeulen L
    Oncogene; 2016 Nov; 35(46):6026-6037. PubMed ID: 27157610
    [TBL] [Abstract][Full Text] [Related]  

  • 88. SNHG14 facilitates cell proliferation in colorectal cancer through targeting KRAS via Hippo-YAP signaling.
    Shen M; Su Y; Song S; Liu D; Liu Z; Chen D; Pan Y; Zhang L; Xu X
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):64-68. PubMed ID: 37300688
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Correlation of miR-31 and miR-373 expression with KRAS mutations and its impact on prognosis in colorectal cancer.
    Ashoori H; Kamian S; Vahidian F; Ghamarchehreh ME
    J Egypt Natl Canc Inst; 2022 Aug; 34(1):35. PubMed ID: 35989410
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Expression profiles of miR-196, miR-132, miR-146a, and miR-134 in human colorectal cancer tissues in accordance with their clinical significance : Comparison regarding KRAS mutation.
    Maralani M; Shanehbandi D; Asadi M; Hashemzadeh S; Hajiasgharzadeh K; Mashhadi Abdolahi H; Baradaran B; Peeters M
    Wien Klin Wochenschr; 2021 Nov; 133(21-22):1162-1170. PubMed ID: 34463887
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.
    Zhang Z; Gao Q; Wang S
    J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Iodine-125 seed represses the growth and facilitates the apoptosis of colorectal cancer cells by suppressing the methylation of miR-615 promoter.
    Ren F; Li B; Wang C; Wang Y; Cui B
    BMC Cancer; 2022 Jan; 22(1):49. PubMed ID: 34998382
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis.
    Zhang H; Xu C; Shi C; Zhang J; Qian T; Wang Z; Ma R; Wu J; Jiang F; Feng J
    J Transl Med; 2021 Mar; 19(1):98. PubMed ID: 33663522
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Active Compound of
    Song J; Seo H; Kim MR; Lee SJ; Ahn S; Song M
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32580297
    [TBL] [Abstract][Full Text] [Related]  

  • 95. SUZ12 depletion suppresses the proliferation of gastric cancer cells.
    Cui Y; Chen J; He Z; Xiao Y
    Cell Physiol Biochem; 2013; 31(6):778-84. PubMed ID: 23735840
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
    Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
    Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Epigenetic silencing and tumor suppressor gene of HAND2 by targeting ERK signaling in colorectal cancer.
    Yuan Z; Yu X; Chen W; Chen D; Cai J; Jiang Y; Liu X; Wu Z; Wang L; Grady WM; Wang H
    Cell Commun Signal; 2022 Jul; 20(1):111. PubMed ID: 35870943
    [TBL] [Abstract][Full Text] [Related]  

  • 98. SLC25A21 downregulation promotes KRAS-mutant colorectal cancer progression by increasing glutamine anaplerosis.
    Hu SS; Han Y; Tan TY; Chen H; Gao JW; Wang L; Yang MH; Zhao L; Wang YQ; Ding YQ; Wang S
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937641
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Sprouty4 is epigenetically upregulated in human colorectal cancer.
    Stuckel AJ; Zeng S; Lyu Z; Zhang W; Zhang X; Dougherty U; Mustafi R; Khare T; Zhang Q; Joshi T; Bissonnette M; Khare S
    Epigenetics; 2023 Dec; 18(1):2145068. PubMed ID: 36384366
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level.
    Hu X; Fatima S; Chen M; Huang T; Chen YW; Gong R; Wong HLX; Yu R; Song L; Kwan HY; Bian Z
    Cell Death Dis; 2021 Nov; 12(11):1053. PubMed ID: 34741022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.